8BSU

Crystal structure of the kainate receptor GluK3-H523A ligand binding domain in complex with kainate and the positive allosteric modulator BPAM344 at 2.9A resolution


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.90 Å
  • R-Value Free: 0.234 
  • R-Value Work: 0.207 
  • R-Value Observed: 0.208 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history


Literature

Small-molecule positive allosteric modulation of homomeric kainate receptors GluK1-3: development of screening assays and insight into GluK3 structure.

Bay, Y.Venskutonyte, R.Frantsen, S.M.Thorsen, T.S.Musgaard, M.Frydenvang, K.Francotte, P.Pirotte, B.Biggin, P.C.Kristensen, A.S.Boesen, T.Pickering, D.S.Gajhede, M.Kastrup, J.S.

(2024) FEBS J 291: 1506-1529

  • DOI: https://doi.org/10.1111/febs.17046
  • Primary Citation of Related Structures:  
    8BST, 8BSU

  • PubMed Abstract: 

    The kainate receptors GluK1-3 (glutamate receptor ionotropic, kainate receptors 1-3) belong to the family of ionotropic glutamate receptors and are essential for fast excitatory neurotransmission in the brain, and are associated with neurological and psychiatric diseases. How these receptors can be modulated by small-molecule agents is not well understood, especially for GluK3. We show that the positive allosteric modulator BPAM344 can be used to establish robust calcium-sensitive fluorescence-based assays to test agonists, antagonists, and positive allosteric modulators of GluK1-3. The half-maximal effective concentration (EC 50 ) of BPAM344 for potentiating the response of 100 μm kainate was determined to be 26.3 μm for GluK1, 75.4 μm for GluK2, and 639 μm for GluK3. Domoate was found to be a potent agonist for GluK1 and GluK2, with an EC 50 of 0.77 and 1.33 μm, respectively, upon co-application of 150 μm BPAM344. At GluK3, domoate acts as a very weak agonist or antagonist with a half-maximal inhibitory concentration (IC 50 ) of 14.5 μm, in presence of 500 μm BPAM344 and 100 μm kainate for competition binding. Using H523A-mutated GluK3, we determined the first dimeric structure of the ligand-binding domain by X-ray crystallography, allowing location of BPAM344, as well as zinc-, sodium-, and chloride-ion binding sites at the dimer interface. Molecular dynamics simulations support the stability of the ion sites as well as the involvement of Asp761, Asp790, and Glu797 in the binding of zinc ions. Using electron microscopy, we show that, in presence of glutamate and BPAM344, full-length GluK3 adopts a dimer-of-dimers arrangement.


  • Organizational Affiliation

    Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Glutamate receptor ionotropic, kainate 3
A, B, C, D, E
A, B, C, D, E, F, G, H
258Rattus norvegicusMutation(s): 1 
Gene Names: Grik3Glur7
UniProt
Find proteins for P42264 (Rattus norvegicus)
Explore P42264 
Go to UniProtKB:  P42264
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP42264
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 7 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
2J9 (Subject of Investigation/LOI)
Query on 2J9

Download Ideal Coordinates CCD File 
EA [auth C]
I [auth A]
NB [auth F]
OA [auth D]
T [auth B]
EA [auth C],
I [auth A],
NB [auth F],
OA [auth D],
T [auth B],
WA [auth E],
WB [auth G],
XA [auth E]
4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide
C10 H11 F N2 O2 S
FLTMTBPCYAZIKM-UHFFFAOYSA-N
KAI (Subject of Investigation/LOI)
Query on KAI

Download Ideal Coordinates CCD File 
CA [auth B]
DC [auth G]
LC [auth H]
MB [auth E]
NA [auth C]
CA [auth B],
DC [auth G],
LC [auth H],
MB [auth E],
NA [auth C],
R [auth A],
UB [auth F],
VA [auth D]
3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE
C10 H15 N O4
VLSMHEGGTFMBBZ-OOZYFLPDSA-N
SO4
Query on SO4

Download Ideal Coordinates CCD File 
BA [auth B]
CC [auth G]
KC [auth H]
LB [auth E]
P [auth A]
BA [auth B],
CC [auth G],
KC [auth H],
LB [auth E],
P [auth A],
Q [auth A],
TA [auth D],
UA [auth D]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
GOL
Query on GOL

Download Ideal Coordinates CCD File 
EB [auth E]
FB [auth E]
GB [auth E]
GC [auth H]
HA [auth C]
EB [auth E],
FB [auth E],
GB [auth E],
GC [auth H],
HA [auth C],
HB [auth E],
IA [auth C],
IB [auth E],
JB [auth E],
L [auth A],
RA [auth D],
SA [auth D],
W [auth B]
GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
ZN
Query on ZN

Download Ideal Coordinates CCD File 
AB [auth E]
BB [auth E]
CB [auth E]
DB [auth E]
EC [auth H]
AB [auth E],
BB [auth E],
CB [auth E],
DB [auth E],
EC [auth H],
FA [auth C],
FC [auth H],
GA [auth C],
J [auth A],
K [auth A],
OB [auth F],
PA [auth D],
PB [auth F],
QA [auth D],
U [auth B],
V [auth B],
XB [auth G],
YA [auth E],
YB [auth G],
ZA [auth E]
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
ACT
Query on ACT

Download Ideal Coordinates CCD File 
DA [auth B],
S [auth A],
VB [auth F]
ACETATE ION
C2 H3 O2
QTBSBXVTEAMEQO-UHFFFAOYSA-M
CL
Query on CL

Download Ideal Coordinates CCD File 
AA [auth B]
AC [auth G]
BC [auth G]
HC [auth H]
IC [auth H]
AA [auth B],
AC [auth G],
BC [auth G],
HC [auth H],
IC [auth H],
JA [auth C],
JC [auth H],
KA [auth C],
KB [auth E],
LA [auth C],
M [auth A],
MA [auth C],
N [auth A],
O [auth A],
QB [auth F],
RB [auth F],
SB [auth F],
TB [auth F],
X [auth B],
Y [auth B],
Z [auth B],
ZB [auth G]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.90 Å
  • R-Value Free: 0.234 
  • R-Value Work: 0.207 
  • R-Value Observed: 0.208 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 83.145α = 90
b = 100.559β = 103.93
c = 132.826γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
SCALAdata scaling
PHASERphasing
XDSdata reduction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2023-12-13
    Type: Initial release
  • Version 1.1: 2024-06-26
    Changes: Database references
  • Version 1.2: 2024-07-03
    Changes: Database references
  • Version 1.3: 2024-11-13
    Changes: Structure summary